Literature DB >> 9186855

Atherosclerosis and arteriosclerosis in chronic renal failure.

G M London, T B Drueke.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9186855     DOI： 10.1038/ki.1997.233

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  41 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  Outcomes after the long interdialytic break: implications for the dialytic prescription.

Authors:  Jennifer E Flythe; Eduardo Lacson
Journal:  Semin Dial       Date:  2012 Jan-Feb       Impact factor: 3.455

Review 3.  The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics.

Authors:  Jeffrey Perl; Laura M Dember; Joanne M Bargman; Teri Browne; David M Charytan; Jennifer E Flythe; LaTonya J Hickson; Adriana M Hung; Michel Jadoul; Timmy Chang Lee; Klemens B Meyer; Hamid Moradi; Tariq Shafi; Isaac Teitelbaum; Leslie P Wong; Christopher T Chan
Journal:  Clin J Am Soc Nephrol       Date:  2017-03-17       Impact factor: 8.237

4.  Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; John J Sim; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 8.237

5.  Nitric oxide regulates tissue transglutaminase localization and function in the vasculature.

Authors:  Simran K Jandu; Alanah K Webb; Alina Pak; Baris Sevinc; Daniel Nyhan; Alexey M Belkin; Nicholas A Flavahan; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Amino Acids       Date:  2011-10-08       Impact factor: 3.520

6.  Anti-Platelet Factor 4/Heparin Antibody Plays a Significant Role in Progression of Arterial Stiffness among Hemodialysis Patients.

Authors:  Chieh Kuo; Chiang-Chin Tsai; Chien-An Chen; Yueh-Feng Tsai; Yen-Hsun Chen
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

7.  Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo.

Authors:  Gunther Marsche; Sasa Frank; Andelko Hrzenjak; Michael Holzer; Sabine Dirnberger; Christian Wadsack; Hubert Scharnagl; Tatjana Stojakovic; Akos Heinemann; Karl Oettl
Journal:  Circ Res       Date:  2009-01-29       Impact factor: 17.367

8.  Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

Authors:  J Jankowski; M van der Giet; V Jankowski; S Schmidt; M Hemeier; B Mahn; G Giebing; M Tolle; H Luftmann; H Schluter; W Zidek; M Tepel
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

9.  Ocular fundus abnormalities in patients with Balkan endemic nephropathy and other chronic kidney diseases.

Authors:  Jasmina Djordjevic Jocic; Rade Cukuranovic; Predrag Jovanovic; Vidosava Djordjevic; Marija Mihajlovic; Dragan Bogdanovic; Jovana Cukuranovic-Kokoris; Vladisav Stefanovic
Journal:  Int Urol Nephrol       Date:  2015-09-02       Impact factor: 2.370

Review 10.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.